Delivery Order SPE2DB20D2002-SPE2DB22FL32K
- Not listed
- The Defense Logistics Agency (DLA) awarded a $17,267.00 delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,557,398 units of Epinephrine 0.3 mg auto-injectors. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., to supply a comprehensive range of pharmaceutical products and medical supplies to support military and...
- The Defense Logistics Agency (DLA) awarded a $16,563.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,661,114 units of Epinephrine 0.3 mg Auto-Injectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,143.03 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.3 mg epinephrine auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC allows DLA to efficiently procure a wide range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,229.29 firm fixed price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for 4,558,566,066 units of epinephrine 0.3 mg auto-injector devices. This order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a wide range of pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,128.60 to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4,564,339,573 units of epinephrine 0.3 mg auto-injector devices. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3 mg auto-injectors. The $13,434.79 firm-fixed-price contract has an ultimate completion date of October 19, 2023. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., to provide a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,588.87 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,359,634 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The Defense Logistics Agency (DLA) awarded a $2,321.66 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,494.50 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,558,189,968 units of epinephrine 0.3 mg auto-injectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a range of pharmaceutical products and medical supplies to support...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,454.11 firm fixed-price delivery order (SPE2DB20D1109|SPE2DB24FN18Y) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to supply Epinephrine 0.3 mg auto-injectors. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL32KDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,202.17 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4556884663 Epinephrine 0.3 mg auto-injectors. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating full and open competition. Amerisourcebergen is a key vendor for various federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs, leveraging its extensive supply chain and distribution capabilities to efficiently fulfill government contracts for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/13/22 |